Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | Zaire ebolavirus glycoprotein |
Clinical data | |
Pronunciation | oh" de siv' i mab |
License data |
|
Drug class | Monoclonal antibody |
ATC code |
|
Identifiers | |
CAS Number | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6506H10024N1720O2030S42 |
Molar mass | 146164.29 g·mol−1 |
Odesivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus ( Ebola virus). [1] [2]
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | Zaire ebolavirus glycoprotein |
Clinical data | |
Pronunciation | oh" de siv' i mab |
License data |
|
Drug class | Monoclonal antibody |
ATC code |
|
Identifiers | |
CAS Number | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C6506H10024N1720O2030S42 |
Molar mass | 146164.29 g·mol−1 |
Odesivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus ( Ebola virus). [1] [2]